[Optimisation of the antibiotic policy in the Netherlands. XII. The SWAB guideline for antimicrobial eradication of MRSA in carriers]
The 'Stichting Werkgroep Antibioticabeleid' (SWAB; Dutch Working Party on Antibiotics Policy) has developed evidence-based guidelines for the antimicrobial treatment of methicillin-resistant Staphylococcus aureus (MRSA) carriers for the eradication of MRSA. A distinction was made between u...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | Dutch; Flemish |
| Published: |
2008
|
| _version_ | 1797063812986175488 |
|---|---|
| author | Wertheim, H Ammerlaan, H Bonten, M van den Broek, P Troelstra, A Vandenbroucke-Grauls, C Vos, M Voss, A Nouwen, J Kluytmans, J |
| author_facet | Wertheim, H Ammerlaan, H Bonten, M van den Broek, P Troelstra, A Vandenbroucke-Grauls, C Vos, M Voss, A Nouwen, J Kluytmans, J |
| author_sort | Wertheim, H |
| collection | OXFORD |
| description | The 'Stichting Werkgroep Antibioticabeleid' (SWAB; Dutch Working Party on Antibiotics Policy) has developed evidence-based guidelines for the antimicrobial treatment of methicillin-resistant Staphylococcus aureus (MRSA) carriers for the eradication of MRSA. A distinction was made between uncomplicated and complicated carriage depending on the presence or absence of an active MRSA infection, skin lesions, foreign body material, mupirocin resistance and/or extranasal carriage. The indication for treatment is determined by the consequences of carriage for the carrier and his/her environment, the adverse events of treatment, and the likelihood of a successful treatment. The first choice of treatment in uncomplicated carriers is a combination of mupirocin nasal ointment and disinfectant soap for 5 days, along with hygiene advice. If treatment fails, sources in the vicinity of the patient must be sought. Complicated carriers receive a combination of 2 oral antibiotics, in addition to mupirocin nasal ointment and disinfectant soap, for at least 7 days. |
| first_indexed | 2024-03-06T21:05:16Z |
| format | Journal article |
| id | oxford-uuid:3c3954be-a697-401e-bf80-f5de9aae1436 |
| institution | University of Oxford |
| language | Dutch; Flemish |
| last_indexed | 2024-03-06T21:05:16Z |
| publishDate | 2008 |
| record_format | dspace |
| spelling | oxford-uuid:3c3954be-a697-401e-bf80-f5de9aae14362022-03-26T14:12:24Z[Optimisation of the antibiotic policy in the Netherlands. XII. The SWAB guideline for antimicrobial eradication of MRSA in carriers]Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:3c3954be-a697-401e-bf80-f5de9aae1436Dutch; FlemishSymplectic Elements at Oxford2008Wertheim, HAmmerlaan, HBonten, Mvan den Broek, PTroelstra, AVandenbroucke-Grauls, CVos, MVoss, ANouwen, JKluytmans, JThe 'Stichting Werkgroep Antibioticabeleid' (SWAB; Dutch Working Party on Antibiotics Policy) has developed evidence-based guidelines for the antimicrobial treatment of methicillin-resistant Staphylococcus aureus (MRSA) carriers for the eradication of MRSA. A distinction was made between uncomplicated and complicated carriage depending on the presence or absence of an active MRSA infection, skin lesions, foreign body material, mupirocin resistance and/or extranasal carriage. The indication for treatment is determined by the consequences of carriage for the carrier and his/her environment, the adverse events of treatment, and the likelihood of a successful treatment. The first choice of treatment in uncomplicated carriers is a combination of mupirocin nasal ointment and disinfectant soap for 5 days, along with hygiene advice. If treatment fails, sources in the vicinity of the patient must be sought. Complicated carriers receive a combination of 2 oral antibiotics, in addition to mupirocin nasal ointment and disinfectant soap, for at least 7 days. |
| spellingShingle | Wertheim, H Ammerlaan, H Bonten, M van den Broek, P Troelstra, A Vandenbroucke-Grauls, C Vos, M Voss, A Nouwen, J Kluytmans, J [Optimisation of the antibiotic policy in the Netherlands. XII. The SWAB guideline for antimicrobial eradication of MRSA in carriers] |
| title | [Optimisation of the antibiotic policy in the Netherlands. XII. The SWAB guideline for antimicrobial eradication of MRSA in carriers] |
| title_full | [Optimisation of the antibiotic policy in the Netherlands. XII. The SWAB guideline for antimicrobial eradication of MRSA in carriers] |
| title_fullStr | [Optimisation of the antibiotic policy in the Netherlands. XII. The SWAB guideline for antimicrobial eradication of MRSA in carriers] |
| title_full_unstemmed | [Optimisation of the antibiotic policy in the Netherlands. XII. The SWAB guideline for antimicrobial eradication of MRSA in carriers] |
| title_short | [Optimisation of the antibiotic policy in the Netherlands. XII. The SWAB guideline for antimicrobial eradication of MRSA in carriers] |
| title_sort | optimisation of the antibiotic policy in the netherlands xii the swab guideline for antimicrobial eradication of mrsa in carriers |
| work_keys_str_mv | AT wertheimh optimisationoftheantibioticpolicyinthenetherlandsxiitheswabguidelineforantimicrobialeradicationofmrsaincarriers AT ammerlaanh optimisationoftheantibioticpolicyinthenetherlandsxiitheswabguidelineforantimicrobialeradicationofmrsaincarriers AT bontenm optimisationoftheantibioticpolicyinthenetherlandsxiitheswabguidelineforantimicrobialeradicationofmrsaincarriers AT vandenbroekp optimisationoftheantibioticpolicyinthenetherlandsxiitheswabguidelineforantimicrobialeradicationofmrsaincarriers AT troelstraa optimisationoftheantibioticpolicyinthenetherlandsxiitheswabguidelineforantimicrobialeradicationofmrsaincarriers AT vandenbrouckegraulsc optimisationoftheantibioticpolicyinthenetherlandsxiitheswabguidelineforantimicrobialeradicationofmrsaincarriers AT vosm optimisationoftheantibioticpolicyinthenetherlandsxiitheswabguidelineforantimicrobialeradicationofmrsaincarriers AT vossa optimisationoftheantibioticpolicyinthenetherlandsxiitheswabguidelineforantimicrobialeradicationofmrsaincarriers AT nouwenj optimisationoftheantibioticpolicyinthenetherlandsxiitheswabguidelineforantimicrobialeradicationofmrsaincarriers AT kluytmansj optimisationoftheantibioticpolicyinthenetherlandsxiitheswabguidelineforantimicrobialeradicationofmrsaincarriers |